Logo image of CFLT

CONFLUENT INC-CLASS A (CFLT) Stock Fundamental Analysis

NASDAQ:CFLT - Nasdaq - US20717M1036 - Common Stock - Currency: USD

26.335  +0.32 (+1.25%)

Fundamental Rating

4

CFLT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. CFLT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CFLT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CFLT was profitable.
In the past year CFLT had a positive cash flow from operations.
In the past 5 years CFLT always reported negative net income.
CFLT had negative operating cash flow in 4 of the past 5 years.
CFLT Yearly Net Income VS EBIT VS OCF VS FCFCFLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

With a Return On Assets value of -11.86%, CFLT is not doing good in the industry: 61.70% of the companies in the same industry are doing better.
CFLT has a worse Return On Equity (-31.22%) than 61.70% of its industry peers.
Industry RankSector Rank
ROA -11.86%
ROE -31.22%
ROIC N/A
ROA(3y)-16.7%
ROA(5y)-21.68%
ROE(3y)-49.8%
ROE(5y)-55.07%
ROIC(3y)N/A
ROIC(5y)N/A
CFLT Yearly ROA, ROE, ROICCFLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

CFLT has a Gross Margin of 73.92%. This is in the better half of the industry: CFLT outperforms 63.12% of its industry peers.
CFLT's Gross Margin has improved in the last couple of years.
CFLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y1.8%
CFLT Yearly Profit, Operating, Gross MarginsCFLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

CFLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CFLT has more shares outstanding
CFLT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CFLT has an improved debt to assets ratio.
CFLT Yearly Shares OutstandingCFLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
CFLT Yearly Total Debt VS Total AssetsCFLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.79 indicates that CFLT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.79, CFLT is in line with its industry, outperforming 54.61% of the companies in the same industry.
The Debt to FCF ratio of CFLT is 145.93, which is on the high side as it means it would take CFLT, 145.93 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CFLT (145.93) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.07 is on the high side and indicates that CFLT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.07, CFLT is doing worse than 73.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 145.93
Altman-Z 2.79
ROIC/WACCN/A
WACC10.84%
CFLT Yearly LT Debt VS Equity VS FCFCFLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.42 indicates that CFLT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.42, CFLT belongs to the top of the industry, outperforming 85.46% of the companies in the same industry.
CFLT has a Quick Ratio of 4.42. This indicates that CFLT is financially healthy and has no problem in meeting its short term obligations.
CFLT's Quick ratio of 4.42 is amongst the best of the industry. CFLT outperforms 85.46% of its industry peers.
Industry RankSector Rank
Current Ratio 4.42
Quick Ratio 4.42
CFLT Yearly Current Assets VS Current LiabilitesCFLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

7

3. Growth

3.1 Past

CFLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 106.25%, which is quite impressive.
Looking at the last year, CFLT shows a very strong growth in Revenue. The Revenue has grown by 24.10%.
The Revenue has been growing by 45.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)106.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)24.1%
Revenue growth 3Y35.44%
Revenue growth 5Y45.1%
Sales Q2Q%24.8%

3.2 Future

CFLT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.35% yearly.
The Revenue is expected to grow by 17.67% on average over the next years. This is quite good.
EPS Next Y23.49%
EPS Next 2Y27.34%
EPS Next 3Y31.6%
EPS Next 5Y31.35%
Revenue Next Year19.67%
Revenue Next 2Y18.97%
Revenue Next 3Y19.07%
Revenue Next 5Y17.67%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CFLT Yearly Revenue VS EstimatesCFLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
CFLT Yearly EPS VS EstimatesCFLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 79.80 indicates a quite expensive valuation of CFLT.
Compared to the rest of the industry, the Price/Earnings ratio of CFLT is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.53. CFLT is valued rather expensively when compared to this.
CFLT is valuated quite expensively with a Price/Forward Earnings ratio of 54.14.
CFLT's Price/Forward Earnings is on the same level as the industry average.
CFLT is valuated rather expensively when we compare the Price/Forward Earnings ratio to 36.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 79.8
Fwd PE 54.14
CFLT Price Earnings VS Forward Price EarningsCFLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CFLT.
Industry RankSector Rank
P/FCF 1195.17
EV/EBITDA N/A
CFLT Per share dataCFLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CFLT's earnings are expected to grow with 31.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.4
PEG (5Y)N/A
EPS Next 2Y27.34%
EPS Next 3Y31.6%

More info and screens

0

5. Dividend

5.1 Amount

CFLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONFLUENT INC-CLASS A

NASDAQ:CFLT (7/23/2025, 1:27:08 PM)

26.335

+0.32 (+1.25%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners91.24%
Inst Owner Change-0.01%
Ins Owners3.66%
Ins Owner Change16.32%
Market Cap8.95B
Analysts79.47
Price Target29.5 (12.02%)
Short Float %7.22%
Short Ratio3.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.23%
Min EPS beat(2)16.38%
Max EPS beat(2)54.07%
EPS beat(4)4
Avg EPS beat(4)47.1%
Min EPS beat(4)16.38%
Max EPS beat(4)91.45%
EPS beat(8)8
Avg EPS beat(8)140.49%
EPS beat(12)12
Avg EPS beat(12)103.24%
EPS beat(16)16
Avg EPS beat(16)82.41%
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-0.32%
Max Revenue beat(2)0.52%
Revenue beat(4)3
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-0.32%
Max Revenue beat(4)0.52%
Revenue beat(8)7
Avg Revenue beat(8)0.62%
Revenue beat(12)11
Avg Revenue beat(12)1.16%
Revenue beat(16)15
Avg Revenue beat(16)3.07%
PT rev (1m)-0.03%
PT rev (3m)-23.03%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)7.99%
EPS NY rev (1m)0.12%
EPS NY rev (3m)2.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.43%
Valuation
Industry RankSector Rank
PE 79.8
Fwd PE 54.14
P/S 8.8
P/FCF 1195.17
P/OCF 279.74
P/B 8.72
P/tB 10.48
EV/EBITDA N/A
EPS(TTM)0.33
EY1.25%
EPS(NY)0.49
Fwd EY1.85%
FCF(TTM)0.02
FCFY0.08%
OCF(TTM)0.09
OCFY0.36%
SpS2.99
BVpS3.02
TBVpS2.51
PEG (NY)3.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.86%
ROE -31.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.92%
FCFM 0.74%
ROA(3y)-16.7%
ROA(5y)-21.68%
ROE(3y)-49.8%
ROE(5y)-55.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y1.8%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 145.93
Debt/EBITDA N/A
Cap/Depr 100.86%
Cap/Sales 2.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.42
Quick Ratio 4.42
Altman-Z 2.79
F-Score6
WACC10.84%
ROIC/WACCN/A
Cap/Depr(3y)149.62%
Cap/Depr(5y)198.26%
Cap/Sales(3y)2.55%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y23.49%
EPS Next 2Y27.34%
EPS Next 3Y31.6%
EPS Next 5Y31.35%
Revenue 1Y (TTM)24.1%
Revenue growth 3Y35.44%
Revenue growth 5Y45.1%
Sales Q2Q%24.8%
Revenue Next Year19.67%
Revenue Next 2Y18.97%
Revenue Next 3Y19.07%
Revenue Next 5Y17.67%
EBIT growth 1Y3.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year373.53%
EBIT Next 3Y131.79%
EBIT Next 5YN/A
FCF growth 1Y103.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.77%
OCF growth 3YN/A
OCF growth 5YN/A